Positron emission tomography in the staging of patients with Hodgkin’s lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi
- 16 August 2007
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 86 (12) , 897-903
Abstract
In this prospective multicentric study, we investigated the contribution of positron emission tomography (PET) scanning to the staging of Hodgkin’s lymphoma (HL) by computed tomography (CT) and attempted to determine whether it has any impact on therapeutic approach. One hundred eighty six consecutive patients with HL from six Italian centers were enrolled in this study. They were staged with conventional methods; 2-[fluorine-18]fluoro-2-deoxy-d-glucose PET scanning were prospectively compared to CT. CT and FDG-PET stages were concordant in 156 patients (84%) and discordant in 30 patients (16%). PET stage in comparison to CT stage was higher in 27 patients (14%) and lower in 3 patients (1%). The programmed treatment strategy was modified in 11 out of 30 patients (37%) after the definition of final stage. If we considered the 123 CT staged patients with localized stage, ten patients (8%) with a change of stage from localized to advanced after PET evaluation were treated with different strategy. FDG-PET was shown to be a relevant, non-invasive method that supplements conventional procedures and should therefore be used routinely to stage HL, particularly in early stage patients, where a change in stage may modify disease management.Keywords
This publication has 17 references indexed in Scilit:
- FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphomaBlood, 2006
- Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?Annals of Oncology, 2005
- Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomasRadiologic Clinics of North America, 2004
- Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's diseaseAnnals of Oncology, 2004
- Non-Hodgkin Lymphoma and Hodgkin Disease: Coregistered FDG PET and CT at Staging and Restaging—Do We Need Contrast-enhanced CT?Radiology, 2004
- Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphomaBritish Journal of Cancer, 2004
- Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- 2-Deoxy-2-[F-18]Fluoro-D-Glucose Imaging with Positron Emission Tomography for Initial Staging of Hodgkin's Disease and LymphomaMolecular Imaging and Biology, 2002
- Staging Hodgkin's Disease with 18-FDG PET Comparison with CT and SurgeryClinical Positron Imaging, 1998
- Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.Journal of Clinical Oncology, 1989